Corpus Intelligence IC Memo — SOUTHWEST MEDICAL CENTER 2026-04-26 04:04 UTC
IC Memo — SOUTHWEST MEDICAL CENTER
Investment Committee Memorandum | KS | 67 beds | Grade C | EBITDA uplift $4.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

SOUTHWEST MEDICAL CENTER

CCN 170068 | SEWARD, KS | 67 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

SOUTHWEST MEDICAL CENTER is a 67-bed under-performing / distressed in SEWARD, KS with $62.9M in net patient revenue and a -22.9% operating margin. The hospital serves a payer mix of 37.4% Medicare, 15.4% Medicaid, and 47.2% commercial.

Thesis: Turnaround. Our ML models identify $4.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -22.9% to -15.5% (+736bps).

Net Revenue HCRIS$62.9M
Current EBITDA COMPUTED$-14.4M
Operating Margin COMPUTED-22.9%
Occupancy HCRIS34.4%
Revenue / Bed COMPUTED$939K
Net-to-Gross HCRIS28.9%
Distress Probability ML55.1%

2. Market Context & Competitive Position

152
KS Hospitals
-17.7%
State Median Margin
33
Comparable Hospitals

KS has 152 Medicare-certified hospitals with a median operating margin of -17.7%. The target's margin of -22.9% places it below the state median. Among 33 size-comparable peers (34-134 beds), the median margin is -6.1%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (34-134), prioritizing same-state peers. 33 hospitals in the comp set.

HospitalStateBedsRevenueMargin
SOUTHWEST MEDICAL CENTER (Target)KS67$62.9M-22.9%
LAWRENCE MEMORIAL HOSPITALKS110$346.7M-4.0%
ST. LUKES SOUTHKS91$218.2M-13.1%
CHILDRENS MERCY HOSPITAL KANSAKS42$108.5M14.7%
CENTURA ST. CATHERINE - GARDENKS90$107.1M-8.1%
MERCY REGIONAL HEALTH CENTERKS84$95.8M0.8%
NEWTON MEDICAL CENTERKS76$93.2M-7.9%
VIA CHRISTI HOSPITAL PITTSBURGKS64$90.4M-16.9%
LABETTE COUNTY MEDICAL CENTERKS49$80.6M-14.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $4.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$1.3M+210bp18mo
Cost to Collect4.5%2.5%$1.3M+200bp12mo
Denial Rate Reduction12.0%6.5%$1.2M+198bp12mo
A/R Days Reduction5200.0%3800.0%$766K+122bp9mo
Clean Claim Rate88.0%96.0%$40K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$1.3M
Cost to Collect
$1.3M
Denial Rate Reduction
$1.2M
A/R Days Reduction
$766K
Clean Claim Rate
$40K
Total EBITDA Uplift$4.6M
Current EBITDA$-14.4M
+ RCM Uplift+$4.6M
Pro Forma EBITDA$-9.8M
Current Margin-22.9%
Pro Forma Margin-15.5%
WC Released (1x)$2.4M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-22.2M$-48.7M0.00x-100.0%
Base (11x exit)10.0x11.0x$-22.2M$-60.7M0.00x-100.0%
Bull Case9.0x11.0x$-19.9M$-52.7M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-19.9M$-63.3M0.00x-100.0%
Bear Case11.0x10.0x$-24.4M$-64.6M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-24.4M$-79.0M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 34.4%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 55.1% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 33 hospitals with 34-134 beds
  • Same-state prioritization (n=34)
  • Comp margins: P25=-17.7% / P50=-6.1% / P75=0.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.